Is ASIX or CC more profitable?

AdvanSix has a net margin of -1.40% compared to Chemours' net margin of -2.64%. Chemours' return on equity of 76.52% beat AdvanSix's return on equity. Company Net Margins Return on Equity Return on Assets AdvanSix -1.40% -2.29% -1.08% Chemours -2.64% 76.52% 1.51%

Does the media refer more to ASIX or CC?

In the previous week, Chemours had 29 more articles in the media than AdvanSix. MarketBeat recorded 35 mentions for Chemours and 6 mentions for AdvanSix. AdvanSix's average media sentiment score of 0.45 beat Chemours' score of 0.07 indicating that AdvanSix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdvanSix 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Chemours 3 Very Positive mention(s) 1 Positive mention(s) 27 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to EMN or CC?

In the previous week, Chemours had 29 more articles in the media than Eastman Chemical. MarketBeat recorded 35 mentions for Chemours and 6 mentions for Eastman Chemical. Eastman Chemical's average media sentiment score of 0.34 beat Chemours' score of 0.07 indicating that Eastman Chemical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Eastman Chemical 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Chemours 3 Very Positive mention(s) 1 Positive mention(s) 27 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, CC or NTR?

Nutrien has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemours $5.81B 0.35 -$386M -$1.02 N/A Nutrien $26.89B 1.26 $2.27B $4.58 15.55

Is CC or NTR more profitable?

Nutrien has a net margin of 7.78% compared to Chemours' net margin of -2.64%. Chemours' return on equity of 76.52% beat Nutrien's return on equity. Company Net Margins Return on Equity Return on Assets Chemours -2.64% 76.52% 1.51% Nutrien 7.78% 8.00% 3.85%

Does the media refer more to CC or NTR?

In the previous week, Chemours had 21 more articles in the media than Nutrien. MarketBeat recorded 35 mentions for Chemours and 14 mentions for Nutrien. Nutrien's average media sentiment score of 0.69 beat Chemours' score of 0.07 indicating that Nutrien is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 3 Very Positive mention(s) 1 Positive mention(s) 27 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Nutrien 7 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, CC or OLN?

Olin has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Olin, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemours $5.81B 0.35 -$386M -$1.02 N/A Olin $6.78B 0.30 -$100.50M -$1.47 N/A

Is CC or OLN more profitable?

Olin has a net margin of -2.49% compared to Chemours' net margin of -2.64%. Chemours' return on equity of 76.52% beat Olin's return on equity. Company Net Margins Return on Equity Return on Assets Chemours -2.64% 76.52% 1.51% Olin -2.49% -6.63% -1.58%

Does the media favor CC or OLN?

In the previous week, Chemours had 26 more articles in the media than Olin. MarketBeat recorded 35 mentions for Chemours and 9 mentions for Olin. Olin's average media sentiment score of 0.16 beat Chemours' score of 0.07 indicating that Olin is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 3 Very Positive mention(s) 1 Positive mention(s) 27 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Olin 0 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, CC or TROX?

Chemours has higher revenue and earnings than Tronox. Chemours is trading at a lower price-to-earnings ratio than Tronox, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemours $5.81B 0.35 -$386M -$1.02 N/A Tronox $2.90B 0.14 -$470M -$3.17 N/A

Is CC or TROX more profitable?

Chemours has a net margin of -2.64% compared to Tronox's net margin of -15.86%. Chemours' return on equity of 76.52% beat Tronox's return on equity. Company Net Margins Return on Equity Return on Assets Chemours -2.64% 76.52% 1.51% Tronox -15.86% -25.02% -5.31%

Does the media refer more to CC or TROX?

In the previous week, Chemours had 21 more articles in the media than Tronox. MarketBeat recorded 35 mentions for Chemours and 14 mentions for Tronox. Tronox's average media sentiment score of 0.62 beat Chemours' score of 0.07 indicating that Tronox is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 3 Very Positive mention(s) 1 Positive mention(s) 27 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Tronox 4 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Chemours (CC) Competitors

$13.27 -0.08 (-0.59%)

Closing price 03:59 PM Eastern

Extended Trading

$13.27 0.00 (-0.01%)

As of 07:38 PM Eastern

Compare

CC vs. ASIX, EMN, NTR, OLN, and TROX

Should you buy Chemours stock or one of its competitors? Chemours's main competitors and comparable companies include AdvanSix (ASIX), Eastman Chemical (EMN), Nutrien (NTR), Olin (OLN), and Tronox (TROX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "chemicals" industry.

How does Chemours compare to AdvanSix?

AdvanSix (NYSE:ASIX) and Chemours (NYSE:CC) are both materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 4.1%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.6%. AdvanSix pays out -76.2% of its earnings in the form of a dividend. Chemours pays out -34.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. AdvanSix has raised its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

AdvanSix has higher earnings, but lower revenue than Chemours. AdvanSix is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdvanSix	$1.52B	0.28	$49.29M	-$0.84	N/A
Chemours	$5.81B	0.35	-$386M	-$1.02	N/A

86.4% of AdvanSix shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 5.0% of AdvanSix shares are held by insiders. Comparatively, 0.9% of Chemours shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

AdvanSix has a net margin of -1.40% compared to Chemours' net margin of -2.64%. Chemours' return on equity of 76.52% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdvanSix	-1.40%	-2.29%	-1.08%
Chemours	-2.64%	76.52%	1.51%

AdvanSix presently has a consensus target price of $20.50, suggesting a potential upside of 30.48%. Chemours has a consensus target price of $17.36, suggesting a potential upside of 30.15%. Given AdvanSix's higher possible upside, equities research analysts clearly believe AdvanSix is more favorable than Chemours.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdvanSix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Chemours	2 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.08

AdvanSix has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Chemours has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market.

In the previous week, Chemours had 29 more articles in the media than AdvanSix. MarketBeat recorded 35 mentions for Chemours and 6 mentions for AdvanSix. AdvanSix's average media sentiment score of 0.45 beat Chemours' score of 0.07 indicating that AdvanSix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdvanSix	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Chemours	3 Very Positive mention(s)	1 Positive mention(s)	27 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

AdvanSix beats Chemours on 10 of the 18 factors compared between the two stocks.

How does Chemours compare to Eastman Chemical?

Eastman Chemical (NYSE:EMN) and Chemours (NYSE:CC) are both mid-cap materials companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

In the previous week, Chemours had 29 more articles in the media than Eastman Chemical. MarketBeat recorded 35 mentions for Chemours and 6 mentions for Eastman Chemical. Eastman Chemical's average media sentiment score of 0.34 beat Chemours' score of 0.07 indicating that Eastman Chemical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Eastman Chemical	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Chemours	3 Very Positive mention(s)	1 Positive mention(s)	27 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Eastman Chemical currently has a consensus target price of $74.79, suggesting a potential upside of 13.89%. Chemours has a consensus target price of $17.36, suggesting a potential upside of 30.15%. Given Chemours' higher probable upside, analysts plainly believe Chemours is more favorable than Eastman Chemical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eastman Chemical	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.33
Chemours	2 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.08

Eastman Chemical has a net margin of 7.15% compared to Chemours' net margin of -2.64%. Chemours' return on equity of 76.52% beat Eastman Chemical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eastman Chemical	7.15%	10.59%	4.28%
Chemours	-2.64%	76.52%	1.51%

Eastman Chemical pays an annual dividend of $3.36 per share and has a dividend yield of 5.1%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.6%. Eastman Chemical pays out 59.7% of its earnings in the form of a dividend. Chemours pays out -34.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Eastman Chemical has raised its dividend for 15 consecutive years. Eastman Chemical is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Eastman Chemical has a beta of 1.07, indicating that its stock price is 7% more volatile than the broader market. Comparatively, Chemours has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market.

Eastman Chemical has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Eastman Chemical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eastman Chemical	$8.75B	0.86	$474M	$5.63	11.66
Chemours	$5.81B	0.35	-$386M	-$1.02	N/A

83.7% of Eastman Chemical shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 2.6% of Eastman Chemical shares are owned by insiders. Comparatively, 0.9% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Eastman Chemical beats Chemours on 14 of the 19 factors compared between the two stocks.

How does Chemours compare to Nutrien?

Chemours (NYSE:CC) and Nutrien (NYSE:NTR) are both materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

76.3% of Chemours shares are owned by institutional investors. Comparatively, 63.1% of Nutrien shares are owned by institutional investors. 0.9% of Chemours shares are owned by company insiders. Comparatively, 3.1% of Nutrien shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.6%. Nutrien pays an annual dividend of $2.20 per share and has a dividend yield of 3.1%. Chemours pays out -34.3% of its earnings in the form of a dividend. Nutrien pays out 48.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nutrien has raised its dividend for 7 consecutive years. Nutrien is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Chemours presently has a consensus target price of $17.36, suggesting a potential upside of 30.15%. Nutrien has a consensus target price of $79.19, suggesting a potential upside of 11.20%. Given Chemours' higher probable upside, equities analysts plainly believe Chemours is more favorable than Nutrien.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	2 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.08
Nutrien	1 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.65

Chemours has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Nutrien has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market.

In the previous week, Chemours had 21 more articles in the media than Nutrien. MarketBeat recorded 35 mentions for Chemours and 14 mentions for Nutrien. Nutrien's average media sentiment score of 0.69 beat Chemours' score of 0.07 indicating that Nutrien is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	3 Very Positive mention(s)	1 Positive mention(s)	27 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nutrien	7 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nutrien has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.81B	0.35	-$386M	-$1.02	N/A
Nutrien	$26.89B	1.26	$2.27B	$4.58	15.55

Nutrien has a net margin of 7.78% compared to Chemours' net margin of -2.64%. Chemours' return on equity of 76.52% beat Nutrien's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-2.64%	76.52%	1.51%
Nutrien	7.78%	8.00%	3.85%

Summary

Nutrien beats Chemours on 13 of the 19 factors compared between the two stocks.

How does Chemours compare to Olin?

Chemours (NYSE:CC) and Olin (NYSE:OLN) are both mid-cap materials companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

Chemours has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Olin has a beta of 1.14, suggesting that its share price is 14% more volatile than the broader market.

Olin has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Olin, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.81B	0.35	-$386M	-$1.02	N/A
Olin	$6.78B	0.30	-$100.50M	-$1.47	N/A

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.6%. Olin pays an annual dividend of $0.80 per share and has a dividend yield of 4.5%. Chemours pays out -34.3% of its earnings in the form of a dividend. Olin pays out -54.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Olin is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Chemours had 26 more articles in the media than Olin. MarketBeat recorded 35 mentions for Chemours and 9 mentions for Olin. Olin's average media sentiment score of 0.16 beat Chemours' score of 0.07 indicating that Olin is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	3 Very Positive mention(s)	1 Positive mention(s)	27 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Olin	0 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Chemours presently has a consensus price target of $17.36, suggesting a potential upside of 30.15%. Olin has a consensus price target of $20.64, suggesting a potential upside of 16.66%. Given Chemours' stronger consensus rating and higher possible upside, equities research analysts clearly believe Chemours is more favorable than Olin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	2 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.08
Olin	3 Sell rating(s)	12 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

Olin has a net margin of -2.49% compared to Chemours' net margin of -2.64%. Chemours' return on equity of 76.52% beat Olin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-2.64%	76.52%	1.51%
Olin	-2.49%	-6.63%	-1.58%

76.3% of Chemours shares are held by institutional investors. Comparatively, 88.7% of Olin shares are held by institutional investors. 0.9% of Chemours shares are held by insiders. Comparatively, 1.6% of Olin shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Chemours beats Olin on 9 of the 17 factors compared between the two stocks.

How does Chemours compare to Tronox?

Chemours (NYSE:CC) and Tronox (NYSE:TROX) are both materials companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

76.3% of Chemours shares are owned by institutional investors. Comparatively, 73.4% of Tronox shares are owned by institutional investors. 0.9% of Chemours shares are owned by insiders. Comparatively, 2.0% of Tronox shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Chemours currently has a consensus target price of $17.36, suggesting a potential upside of 30.15%. Tronox has a consensus target price of $5.04, suggesting a potential upside of 92.58%. Given Tronox's higher probable upside, analysts plainly believe Tronox is more favorable than Chemours.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	2 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.08
Tronox	4 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, Chemours had 21 more articles in the media than Tronox. MarketBeat recorded 35 mentions for Chemours and 14 mentions for Tronox. Tronox's average media sentiment score of 0.62 beat Chemours' score of 0.07 indicating that Tronox is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	3 Very Positive mention(s)	1 Positive mention(s)	27 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tronox	4 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Chemours has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Tronox has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market.

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.6%. Tronox pays an annual dividend of $0.20 per share and has a dividend yield of 7.6%. Chemours pays out -34.3% of its earnings in the form of a dividend. Tronox pays out -6.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Chemours has a net margin of -2.64% compared to Tronox's net margin of -15.86%. Chemours' return on equity of 76.52% beat Tronox's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-2.64%	76.52%	1.51%
Tronox	-15.86%	-25.02%	-5.31%

Chemours has higher revenue and earnings than Tronox. Chemours is trading at a lower price-to-earnings ratio than Tronox, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.81B	0.35	-$386M	-$1.02	N/A
Tronox	$2.90B	0.14	-$470M	-$3.17	N/A

Summary

Chemours beats Tronox on 13 of the 18 factors compared between the two stocks.

Get Chemours News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CC vs. The Competition

Export

Metric	Chemours	Chemicals Industry	Materials Sector	NYSE Exchange
Market Cap	$2.01B	$11.44B	$4.62B	$23.48B
Dividend Yield	2.62%	3.00%	4.31%	3.79%
P/E Ratio	-13.01	31.27	26.48	24.81
Price / Sales	0.34	2.40	5.87	3.31
Price / Cash	4.05	14.76	20.84	15.51
Price / Book	12.76	3.44	4.07	3.72
Net Income	-$386M	$235.78M	$159.56M	$1.08B
7 Day Performance	4.32%	-0.01%	-1.72%	0.60%
1 Month Performance	0.81%	-1.38%	-6.60%	-0.29%
1 Year Performance	7.94%	11.28%	7.51%	6.82%

Chemours Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CC Chemours	4.0866 of 5 stars	$13.27 -0.6%	$17.36 +30.8%	+5.6%	$2.01B	$5.81B	N/A	5,700	Options Volume
ASIX AdvanSix	4.0682 of 5 stars	$15.62 -7.2%	$20.50 +31.3%	-3.0%	$419.06M	$1.52B	N/A	1,410
EMN Eastman Chemical	4.9647 of 5 stars	$65.46 +1.6%	$74.79 +14.2%	+7.8%	$7.73B	$8.75B	11.63	13,000	Analyst Forecast
NTR Nutrien	4.7465 of 5 stars	$72.28 +1.1%	$79.24 +9.6%	+18.4%	$34.25B	$26.89B	17.00	25,100	Analyst Forecast
OLN Olin	3.3183 of 5 stars	$17.55 +1.4%	$20.64 +17.6%	-11.1%	$2.06B	$6.78B	N/A	7,849	Dividend Announcement

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CC) was last updated on 11/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chemours (CC) Competitors